CRM vs EBS · P/E 41, rev $41.52B vs rev $1.04B
Salesforce.com Inc (CRM) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Salesforce.com Inc (CRM) is a software - application company listed on US. It is led by Marc Benioff.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CRM revenue for 2026-01-31 was $41.52B. Net income was $7.46B. Revenue was up 9.6% from 2025-01-31 to 2026-01-31. CRM currently screens at market cap $252.36B and trailing P/E 41.3.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CRM currently screens at market cap $252.36B and trailing P/E 41.3. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CRM and EBS stock pages for the full models.
Not investment advice.